Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

Lilly image

Lilly and Boehringer diabetes biosimilar sees EU approval

September 11, 2014
Sales and Marketing Boehringer, EU, European Commission, Lantus, Sanofi, diabetes, lilly

Lilly and Boehringer Ingelheim’s insulin glargine product has been shown the green light by the European Commission (EC). The copycat …

News
Evotec image

Trial misconduct halts Evotec/Hyperion drug

September 10, 2014
Research and Development, Sales and Marketing DiaPep277, Evotec, amdromeda, diabetes, hyperion

Development of Evotec and Hyperion Therapeutic’s diabetes drug DiaPep277 has been terminated following ‘serious misconduct’ in one of its trials. …

News
Novo Nordisk image

Novo Nordisk scraps inflammatory disorders business

September 2, 2014
Research and Development, Sales and Marketing Danish, IL20, Novo Nordisk, diabetes, inflammatory, thomsen

A restructuring of Novo Nordisk will see it completely drop its inflammatory disorders activities in favour of concentrating on its …

News
AstraZeneca image

AZ and Mitsubishi partner on diabetic nephropathy

August 20, 2014
Research and Development, Sales and Marketing AstraZeneca, BMS, Mitsubishi, cvmd, diabetes, nephropathy

AstraZeneca and Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) have signed a new three-year research deal in the area of …

News
afrezza image

Sanofi signs $925 million inhaled insulin deal

August 13, 2014
Sales and Marketing Afrezza, French, Sanofi, diabetes, fad, insulin

Sanofi could pay out as much as $925 million for global rights to the world’s only approved inhaled insulin just …

News
nhsscaffoldingcover_18

Cost of diabetes treatment soars in England

August 13, 2014
Medical Communications, Research and Development, Sales and Marketing Lantus, NHS, Sanofi, diabetes

The NHS spent more than £2.2 million on average every day over the last financial year on diabetes medicines, according …

News
Lens image

Novartis forms alliance with Google on ‘smart lens’

July 15, 2014
Medical Communications, Sales and Marketing Alcon, Novartis, diabetes, e-health, google, smart lens, wearable

Novartis eye care division Alcon has struck a deal with Google to develop a ‘smart’ contact lens designed to help …

News

Rise in diabetes ‘alarming’

July 7, 2014
Sales and Marketing NHS, diabetes, nhs scotland, type 2

NHS Scotland has spent around £230 million on diabetes and obesity drugs in the past three years, according to data …

News
Affreza image

FDA ‘yes’ to inhaled insulin

June 30, 2014
Manufacturing and Production, Sales and Marketing Afrezza, FDA, Mannkind, diabetes, insulin human

The FDA has approved the first ‘ultra-rapid-acting’ mealtime insulin therapy available in the US, to improve glycemic control in both …

News
Janssen image

NICE recommends tenth diabetes drug

June 26, 2014
Sales and Marketing Janssen, NHS, diabetes, invokana, type 2

In final guidance NICE has recommended Janssen’s Invokana as a treatment to help lower blood sugar levels in people with …

News
Medtronic image

Sanofi and Medtronic partner on diabetes

June 16, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, diabetes, medtronic

Sanofi and Medtronic have announced a new tie-up that will see both firms develop new products in the increasingly competitive …

News
Novo image

Novo Nordisk outlines hiring plans

June 12, 2014
Sales and Marketing Denmark, Novo Nordisk, diabetes, haemostasis, pharma

Novo Nordisk has outlined ambitious plans for the medium-term, saying it will look to hire 6,000 staff in its native …

News

Sales forecasts leave Sovaldi top and Januvia lagging

May 23, 2014
Sales and Marketing Gilead, Januvia, Merck, diabetes, ep, hep C, sovaldi

Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …

News
Afrezza image

Inhaled insulin one step closer to approval

April 3, 2014
Sales and Marketing Afrezza, FDA, Mannkind, diabetes, type 1, type 2

After a rocky few years MannKind’s inhaled insulin Afrezza finally looks to be on the path to approval in the …

News
GSK image

Europe grants Eperzan licence

March 27, 2014
Sales and Marketing Bydureon, GSK, diabetes, eperzan, lilly

The European Commission has granted marketing authorisation to GlaxoSmithKline’s new diabetes treatment Eperzan – setting the manufacturer on a collision …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026